Symbol
LCTX on NYSE
Investment type
Equity / Common shares
Latest Disclosed Shares Owned
57,848,357 shares
Security Ownership %
23%

NEAL C. BRADSHER ownership in Lineage Cell Therapeutics, Inc. Common shares (LCTX)

14 Nov 2025 - NEAL C. BRADSHER has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 57,848,357 shares of Lineage Cell Therapeutics, Inc. Common shares (LCTX). This represents 23% ownership of the company. In their previous filing dated 28 Jan 2025, BROADWOOD PARTNERS, L.P. had reported owning 57,848,357 shares, indicating a new holding.